Dashboard
Manage Tickers

CHE


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

caterpillar-posts-upbeat-q3-results-joins-united-therapeutics-centene-fortive-and-other-big-stocks-moving-higher-on-wednesday
Caterpillar Posts Upbeat Q3 Results, Joins...
10/29/2025 14:46:09

chemed-affirms-fy2025-adj-eps-guidance-of-2200-2230-vs-2215-est
Chemed Affirms FY2025 Adj EPS Guidance of ...
10/28/2025 20:18:07

Chemed (NYSE:CHE) affirms FY2025 Adj EPS guidance from $22.00-$22.30 to $22.00-$22.30 vs $22.15 analyst estimate..

chemed-q3-adj-eps-527-misses-536-estimate-sales-624900m-miss-626034m-estimate
Chemed Q3 Adj. EPS $5.27 Misses $5.36 Esti...
10/28/2025 20:17:08

Chemed (NYSE:CHE) reported quarterly earnings of $5.27 per share which missed the analyst consensus estimate of $5.36 by 1.59 p...

earnings-scheduled-for-october-28-2025
Earnings Scheduled For October 28, 2025
10/28/2025 11:11:34

earnings-outlook-for-chemed
Earnings Outlook For Chemed
10/27/2025 18:02:21

b-of-a-securities-maintains-buy-on-chemed-lowers-price-target-to-595
B of A Securities Maintains Buy on Chemed,...
09/10/2025 15:16:50

B of A Securities analyst Joanna Gajuk maintains Chemed (NYSE:CHE) with a Buy and lowers the price target from $610 to $595.

alphabet-to-rally-around-23-here-are-10-top-analyst-forecasts-for-wednesday
Alphabet To Rally Around 23%? Here Are 10 ...
09/03/2025 12:25:40

forecasting-the-future-6-analyst-projections-for-chemed
Forecasting The Future: 6 Analyst Projecti...
09/02/2025 22:02:11

alibaba-to-rally-more-than-12-here-are-10-top-analyst-forecasts-for-tuesday
Alibaba To Rally More Than 12%? Here Are 1...
09/02/2025 12:05:01

this-zscaler-analyst-turns-bullish-here-are-top-4-upgrades-for-tuesday
This Zscaler Analyst Turns Bullish; Here A...
09/02/2025 11:39:34

jefferies-upgrades-chemed-to-buy-raises-price-target-to-550
Jefferies Upgrades Chemed to Buy, Raises P...
09/02/2025 10:06:27

Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $490 to $550.

chemed-board-formally-authorizes-additional-300m-for-stock-repurchase-raises-quarterly-cash-dividend-by-20-from-050-to-060-per-share
Chemed Board Formally Authorizes Additiona...
08/01/2025 16:53:17

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million fo...

rbc-capital-maintains-outperform-on-chemed-lowers-price-target-to-589
RBC Capital Maintains Outperform on Chemed...
07/31/2025 16:04:06

RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Outperform and lowers the price target from $640 to $589.

heres-how-much-100-invested-in-chemed-15-years-ago-would-be-worth-today
Here's How Much $100 Invested In Chemed 15...
07/31/2025 15:15:28

analyst-expectations-for-chemeds-future
Analyst Expectations For Chemed's Future
07/31/2025 13:00:52

oppenheimer-maintains-outperform-on-chemed-lowers-price-target-to-580
Oppenheimer Maintains Outperform on Chemed...
07/31/2025 12:47:58

Oppenheimer analyst Michael Wiederhorn maintains Chemed (NYSE:CHE) with a Outperform and lowers the price target from $650 t...

chemed-appoints-joel-l-wherley-to-succeed-nicholas-m-westfall-as-vitas-ceo
Chemed Appoints Joel L. Wherley To Succeed...
07/29/2025 20:43:33

After a successful sixteen-year career, Executive Vice President of Chemed and Chairman and Chief Executive Officer of VITAS, N...

chemed-lowers-fy2025-adj-eps-guidance-from-2495-2545-to-2200-2230-vs-2333-est
Chemed Lowers FY2025 Adj EPS Guidance from...
07/29/2025 20:27:42

Chemed (NYSE:CHE) lowers FY2025 Adj EPS guidance from $24.95-$25.45 to $22.00-$22.30 vs $23.33 analyst estimate..

chemed-q2-adj-eps-427-misses-508-estimate-sales-61880m-miss-63403m-estimate
Chemed Q2 Adj. EPS $4.27 Misses $5.08 Esti...
07/29/2025 20:17:31

Chemed (NYSE:CHE) reported quarterly earnings of $4.27 per share which missed the analyst consensus estimate of $5.08 by 15.86 ...

Core News & Articles
Earnings Scheduled For July 29, 2025
07/29/2025 08:32:31

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION